Jump to main content
Jump to site search

Issue 36, 2017
Previous Article Next Article

Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease

Author affiliations

Abstract

A quinazoline and pyrido[3,2-d]pyrimidine based compound library was designed, synthesized and evaluated as multi-targeting agents aimed at Alzheimer's disease (AD). The SAR studies identified compound 8h (8-chloro-N2-isopropyl-N4-phenethylquinazoline-2,4-diamine) as a potent inhibitor of Aβ40 aggregation (IC50 = 900 nM) which was 3.6-fold more potent compared to the reference agent curcumin (Aβ40 IC50 = 3.3 μM). It also exhibited dual ChE inhibition (AChE IC50 = 8.6 μM; BuChE IC50 = 2.6 μM). Compound 9h (8-chloro-N4-(3,4-dimethoxyphenethyl)-N2-isopropylquinazoline-2,4-diamine) was identified as the most potent Aβ42 aggregation inhibitor (IC50 ∼ 1.5 μM). Transmission electron microscopy (TEM) imaging demonstrates their anti-Aβ40/Aβ42 aggregation properties. Compound 8e was identified as a potent BuChE inhibitor (BuChE IC50 = 100 nM) which was 36-fold more potent compared to donepezil (BuChE IC50 = 3.6 μM). The pyrido[3,2-d]pyrimidine bioisostere 10b (N2-isopropyl-N4-phenethylpyrido[3,2-d]pyrimidine-2,4-diamine) exhibited good anti-Aβ activity (Aβ40 IC50 = 1.1 μM), dual ChE inhibition and iron-chelating properties (23.6% chelation at 50 μM). These investigations demonstrate the usefulness of either a quinazoline or a pyrido[3,2-d]pyrimidine based ring scaffold in the design of multi-targeting agents to treat AD.

Graphical abstract: Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease

Back to tab navigation

Supplementary files

Publication details

The article was received on 09 Mar 2017, accepted on 17 Apr 2017 and first published on 24 Apr 2017


Article type: Paper
DOI: 10.1039/C7RA02889J
RSC Adv., 2017,7, 22360-22368
  • Open access: Creative Commons BY license
  •   Request permissions

    Application of quinazoline and pyrido[3,2-d]pyrimidine templates to design multi-targeting agents in Alzheimer's disease

    T. Mohamed, M. K. Mann and P. P. N. Rao, RSC Adv., 2017, 7, 22360
    DOI: 10.1039/C7RA02889J

    This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements